Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based Study

  • Philipp Mahlknecht*
  • , Simon Leiter
  • , Corinne Horlings
  • , Katarína Schwarzová
  • , Iris Egner
  • , Heike Stockner
  • , Kathrin Marini
  • , Christoph Theyer
  • , Laura Zamarian
  • , Atbin Djamshidian
  • , Klaus Seppi
  • , Fernanda Farfan
  • , Alicia Garrido
  • , Soumyabrata Ghosh
  • , Rejko Krüger
  • , Deborah McIntyre
  • , Brit Mollenhauer
  • , Alastair Noyce
  • , Claire Pauly
  • , Daniel F. Pilco-Janeta
  • Kavita Rege, Venkata P. Satagopam, Sebastian Schade, Cristina Simonet, Claudia Trenkwalder, Werner Poewe*, Gregor Bletzacher, Atbin Djamshidian, Hannah Egger, Iris Egner, Fernanda Farfan, Tobias Fischnaller, Alicia Garrido, Lena Gatterer, Soumyabrata Ghosh, Valentin Groues, Somaye Hajian-Tilaki, Horst Hakelberg, Beatrice Heim, Sahra Henze, Corinne Horlings, Sonja Jonsdottir, Florian Krismer, Rejko Krüger, Elisabeth Lang, Tainá M. Marques, Deborah Mcintyre, Ulf Nehrbass, Olena Tsurkalenko, Carlos Vega, the HeBA Consortium
*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Background: Preferences for risk disclosure in population-based studies assessing Parkinson's disease (PD) risk have not been assessed so far. Objectives: To examine preferences for risk disclosure in a subset of the European Healthy Brain Aging (HeBA) multicenter study. Methods: After a remote PD risk assessment, a structured pilot-questionnaire on risk disclosure was first presented to participants (≥50 years, without neurodegenerative diseases) during in-person visits at the Innsbruck study site. Results: From the included 81 participants (63% females, median age 65 years), 79% expressed an unconditional desire to be informed about their PD risk. Confronted with a hypothetical scenario of a positive, specific PD test, most would try to live a healthier lifestyle. Regarding future placebo-controlled disease-modification trials, 66% stated they would probably or definitely participate. Conclusions: This pilot-study shows an open-minded view of participants towards disclosure of risk for future PD and a proactive attitude regarding dealing with one's risk.

Original languageEnglish
Pages (from-to)203-209
Number of pages7
JournalMovement Disorders Clinical Practice
Volume12
Issue number2
Early online date18 Nov 2024
DOIs
Publication statusPublished - 18 Nov 2024

Keywords

  • autonomy
  • ethical principle
  • hyposmia
  • neuroprotection
  • return of results
  • risk disclosure

Fingerprint

Dive into the research topics of 'Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based Study'. Together they form a unique fingerprint.

Cite this